• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

5-氨甲基咔唑衍生物的设计、合成及抗阿尔茨海默病活性

陈萌菲, 房雷, 陈莉

陈萌菲, 房雷, 陈莉. 5-氨甲基咔唑衍生物的设计、合成及抗阿尔茨海默病活性[J]. 中国药科大学学报, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602
引用本文: 陈萌菲, 房雷, 陈莉. 5-氨甲基咔唑衍生物的设计、合成及抗阿尔茨海默病活性[J]. 中国药科大学学报, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602
CHEN Mengfei, FANG Lei, CHEN Li. Design, synthesis and anti-Alzheimer′s disease activity of 5-akylaminomethyl substituted carbazole derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602
Citation: CHEN Mengfei, FANG Lei, CHEN Li. Design, synthesis and anti-Alzheimer′s disease activity of 5-akylaminomethyl substituted carbazole derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602

5-氨甲基咔唑衍生物的设计、合成及抗阿尔茨海默病活性

Design, synthesis and anti-Alzheimer′s disease activity of 5-akylaminomethyl substituted carbazole derivatives

  • 摘要: 以5-氨甲基咔唑为先导物,在其母环及5-位氨甲基的氮原子上引入不同的取代基,设计、合成了一系列咔唑衍生物,测试了其乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)抑制活性,以及体外神经元细胞保护活性,并总结了构效关系。其中,化合物 8a 具有AChE/BChE双重抑制活性,同时还能够有效保护PC12细胞免受Aβ造成的损伤,展现出良好的开发前景。
    Abstract: A series of carbazole derivatives were designed and synthesized via the introduction of various substituents on the carbazole template and the nitrogen atom using 5-aminomethyl substituted carbazole as the lead compound. The inhibitory activity towards AChE/BChE and the neuroprotective effect against Aβ-induced toxicity were evaluated by Ellman and MTT assay, respectively. Furthermore, the SAR of the target compounds was discussed. Among all the target compounds, compound 8a showed dual inhibitory activity toward both AChE and BChE, and could effectively protect PC12 cells from Aβ-induced toxicity, indicating compound 8a could be considered as a promising candidate against Alzheimer′s disease.
  • [1] Querfurth HW,LaFerla FM.Alzheimer′s disease[J].N Engl J Med,2010,362(4):329-344.
    [2] Watkins PB,Zimmerman HJ,Knapp MJ,et al.Hepatotoxic effects of tacrine administration in patients with Alzheimer′s disease[J].J Am Med Assoc,1994,271(13):992-998.
    [3] Mullane K,Williams M.Alzheimer′stherapeutics:continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond[J]?Biochem Pharmacol,2013,85(3):289-305.
    [4] Walsh DM,Selkoe DJ.Abetaoligomers-adecade of discovery[J].J Neurochem,2007,101(5):1172-1184.
    [5] Yang W,Wong Y,Ng OT,et al.Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores[J].Angew Chem Int Ed Engl,2012,51(8):1804-1810.
    [6] Fang L,Fang XB,Gou SH,et al.Design,synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents[J].Eur J Med Chem,2014,76:376-386.
    [7] Ellman GL,Courtney KD,Andres V,et al.A new and rapid colorimetric determination of acetylcholinesterase activity[J].Biochem Pharmacol,1961,7:88-95.
    [8] Fang L, Appenroth D, Decker M, et al. Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates[J].J Med Chem,2008,51(4):713-716.
    [9] Dahlgren KN,Manelli AM,StineWB,et al.Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability[J].J Biol Chem,2002,277(35):32046-32053.
计量
  • 文章访问数:  1285
  • HTML全文浏览量:  1
  • PDF下载量:  1790
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭